相关实验视频
Updated: Jan 16, 2026

06:51
A Preclinical Murine Model of Hepatic Metastases
Published on: September 27, 2014
30.2K
一个循环RNA通过稳定MSI2蛋白在胰腺管道腺癌中促进瘤转移
Zhang Li1, Lanyang Gao1, Yang Yang2
1Center for Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu 610041, China.
Research (Washington, D.C.)
|October 6, 2025
概括
像circPRKD3这样的循环RNAs (circRNAs) 驱动胰腺癌转移. 在血清中检测circPRKD3可以改善胰腺管道腺癌 (PDAC) 患者的诊断和预后.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 胰腺管道腺癌 (PDAC) 转移是癌症死亡的主要原因.
- 循环RNAs (circRNAs) 越来越被认为是瘤进展的关键调节者,但它们在PDAC中的具体作用尚未明确.
研究的目的:
- 为了识别和描述参与PDAC转移的新型circRNAs.
- 研究PDAC中circPRKD3的功能作用和分子机制.
- 评估circPRKD3作为PDAC的潜在诊断和预后生物标志物.
主要方法:
- 在PDAC瘤和相邻的正常组织上进行了全面的circRNA分析.
- 使用功能性测试 (体外和体内) 来评估circPRKD3过度表达和淘汰对PDAC细胞行为的影响.
- 机理学研究研究了circPRKD3和Musashi-2 (MSI2) 之间的相互作用.
- 进行了临床相关性分析和液体活检验证.
主要成果:
- 与正常组织相比,PDAC组织中circPRKD3 (hsa_circ_0000992) 的高调显著.
- 过度表达circPRKD3促进了PDAC细胞迁移,入侵和转移,而敲击抑制了这些过程.
- 发现circPRKD3通过防止其降解来稳定致癌性RNA结合蛋白Musashi-2.
- 升高的circPRKD3表达与较短的患者存活率相关,并且在与常规生物标志物结合时显示出作为诊断标志物的潜力.
结论:
- circPRKD3通过稳定Musashi-2在促进PDAC转移方面发挥着至关重要的作用.
- circPRKD3代表了PDAC进展中的新型circRNA介导的调节途径.
- circPRKD3是胰腺管腺癌的有前途的诊断和预后生物标志物,有可能用于液体活检.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K

